Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.155 USD | -2.74% | +0.98% | -33.89% |
06-05 | Transcript : Syros Pharmaceuticals, Inc. - Shareholder/Analyst Call | |
05-14 | Transcript : Syros Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.89% | 142M | |
+52.15% | 59.28B | |
+41.42% | 40.94B | |
-5.21% | 40.17B | |
-5.16% | 28.69B | |
+13.07% | 26.63B | |
-20.48% | 18.89B | |
+31.32% | 12.46B | |
+0.21% | 12.42B | |
+25.18% | 12.26B |
- Stock Market
- Equities
- SYRS Stock
- News Syros Pharmaceuticals, Inc.
- Transcript : Syros Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024